Trial Profile
Effect of Evacetrapib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Evacetrapib (Primary) ; Warfarin
- Indications Atherosclerosis; Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 12 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 Jun 2014 New trial record